Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Saxagliptin Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 13,826Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Reddy's Generic Metformin & Saxagliptin Hydrochloride Receives Approval in the U.S.
    Dr. Reddy's Generic Metformin & Saxagliptin Hydrochloride Receives Approval in the U.S.

    09 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207678

    FDA
    09 Aug 2023
    Share Share
    Sun Pharm`s Generic Saxagliptin HCL Receives Tentative Approval In Us
    Sun Pharm`s Generic Saxagliptin HCL Receives Tentative Approval In Us

    05 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206078

    FDA
    05 Mar 2020
    Share Share
    Merck's DPP-4 newcomer Marizev trails Januvia in safety: Report
    Merck's DPP-4 newcomer Marizev trails Januvia in safety: Report

    15 Apr 2016

    // Emily Wasserman FIERCE PHARMA

    http://www.fiercepharma.com/pharma/merck-s-dpp-4-newcomer-marizev-trails-januvia-safety-report

    Emily Wasserman FIERCE PHARMA
    15 Apr 2016
    Share Share
    Colombian government recommendation puts Novartis cancer drug patent at jeopardy
    Colombian government recommendation puts Novartis cancer drug patent at jeopardy

    08 Mar 2016

    // Ed Silverman STAT

    http://www.statnews.com/pharmalot/2016/03/07/novartis-gleevec-cancer/

    Ed Silverman STAT
    08 Mar 2016
    Share Share
    FDA warning on J&J's Invokana adds more complexities to diabetes drug battles
    FDA warning on J&J's Invokana adds more complexities to diabetes drug battles

    12 Sep 2015

    // Eric Palmer FIERCE PHARMA

    http://www.fiercepharma.com/story/fda-warning-jjs-invokana-adds-more-complexities-diabetes-drug-battles/2015-09-11?utm_medium=rss&utm_source=rss&utm_campaign=rss

    Eric Palmer FIERCE PHARMA
    12 Sep 2015
    Share Share
    FDA warns of severe joint pain risk with DPP-4 diabetes drugs
    FDA warns of severe joint pain risk with DPP-4 diabetes drugs

    29 Aug 2015

    // Toni Clarke REUTERS

    http://in.reuters.com/article/2015/08/28/us-diabetes-drugs-warning-idINKCN0QX25E20150828

    Toni Clarke REUTERS
    29 Aug 2015
    Share Share